Get started
Author

Oleksiy Gridnyev

Observed names: A. E. Gridnev, A. Y. Gridnyev, Gridnyev Oleksiy Ievgeniovych, Gridnyev, O., Gridnyev, Oleksiy, O Gridniev, O. E. Gridnev, O. Y. Gridnyev, O. Ye. Gridniev, O. Ye. Gridnyev, O.Yе. Gridnyev, O. E. Gridnev, O. E. Gridnyev, O. Y. Gridnyev, O. Ye. Gridnev, О. Gridnyev, О.Є. Гріднєв, О. Y. Gridnyev
ORCID: 0000-0003-4716-3520
Observed ORCID: 0000-0003-4716-3520
OpenAlex ID: A5013313586
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group
2020 · Josbert J. Keller, Rogier E. Ooijevaar, et al. · United European Gastroenterology Journal · 168
PDF
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
2024 · David T Rubin, Jessica R Allegretti, et al. · The Lancet · 141
PDF
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg)
2024 · Llum Olmedo, Xavier Calvet, et al. · Gut · 56
PDF
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management
2024 · Jose M. Huguet, Luis Ferrer‐Barceló, et al. · United European Gastroenterology Journal · 53
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
2021 · Olga P. Nyssen, Dino Vaira, et al. · Clinical Gastroenterology and Hepatology · 38
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management
2023 · Natalia García-Morales, Ángeles Pérez-Aísa, et al. · Journal of Clinical Medicine · 22
PDF
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)
2025 · Diego Casas Deza, Javier Alcedo, et al. · The American Journal of Gastroenterology · 20
Comparison of the management of Helicobacter pylori infection between the older and younger European populations
2023 · Paulius Jonaitis, Olga P. Nyssen, et al. · Scientific Reports · 19
Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)
2022 · Diego Burgos-Santamaría, Olga P Nyssen, et al. · Gut · 11
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg)
2023 · Olga P. Nyssen, Pietro Pratesi, et al. · Antibiotics · 10
PDF
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐ EuReg )
2024 · Samuel J. Martínez‐Domínguez, Olga P. Nyssen, et al. · Helicobacter · 6
PDF
Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp‐ EuReg )
2026 · Olga P. Nyssen, Laimas Jonaitis, et al. · Helicobacter · 5
UEG Week 2023 Moderated Posters
2023 · Casas Deza, Diego, Alcedo, Javier, et al. · United European Gastroenterology Journal · 3
PDF
Gut microbiota changes in nonalcoholic fatty liver disease and concomitant coronary artery disease
2023 · Galyna Fadieienko, Oleksiy Gridnyev, et al. · Cor et Vasa · 3
PDF
Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations
2023 · Paulius Jonaitis, Olga P. Nyssen, et al. · Scientific Reports · 2
PDF
UEG Week 2023 Poster Presentations
2023 · Casas Deza, Diego, Alcedo, Javier, et al. · United European Gastroenterology Journal · 2
The relationship between intestinal microbiota and systemic inflammation in patients with non-alcoholic fatty liver disease
2021 · G. D. Fadieienko, I. E. Kushnir, et al. · Modern Gastroenterology · 2
Characteristics of intestinal dysbiosis in patients with non-alcoholic fatty liver disease
2020 · G. D. Fadieienko, A. Y. Gridnyev, et al. · Modern Gastroenterology · 2
Efficiency and safety of ademetionine in the correction of liver function in patients with steatohepatitis. Results of an open multicenter comparative post-marketing study
2019 · G. D. Fadieienko, I. M. Skrypnyk, et al. · Modern Gastroenterology · 2
The relationship of serum inflammatory markers with metabolic disorders at the non-alcoholic fatty liver disease
2018 · G. D. Fadieienko, I. E. Kushnir, et al. · Modern Gastroenterology · 2
The role of the gut microbiome and metabolome in potentializing metabolic health disorders. Review
2026 · G. D. Fadieienko, O. Y. Gridnyev · Modern Gastroenterology · 1
UEG Week 2025 Poster Presentations
2025 · Parra, P., Jonaitis, Laimas Virginijus, et al. · United European Gastroenterology Journal · 1
New perspectives on treatment of overweight and obesity. Review
2025 · G. D. Fadieienko, O. O. Buriakovska, et al. · Modern Gastroenterology · 1
Type 3c diabetes mellitus: what are we dealing with? Review
2024 · G. D. Fadieienko, O. Y. Gridnyev, et al. · Ukrainian Therapeutical Journal · 1
Nonalcoholic fatty liver disease and cardiovascular risk. Literature review
2024 · G. D. Fadieienko, O. Y. Gridnyev, et al. · Ukrainian Therapeutical Journal · 1
Works count: 89
Citation count: 581
H-index: 10
I10-index: 10
Year
Topic
Type